Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis.

Winters ZE, Hunt NC, Bradburn MJ, Royds JA, Turley H, Harris AL, Norbury CJ.

Eur J Cancer. 2001 Dec;37(18):2405-12.

PMID:
11720835
2.

Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.

Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma VM.

Br J Cancer. 1999 Aug;80(12):2001-7.

3.

Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.

Kourea HP, Koutras AK, Scopa CD, Marangos MN, Tzoracoeleftherakis E, Koukouras D, Kalofonos HP.

Mol Pathol. 2003 Dec;56(6):328-35.

4.

Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.

Werness BA, Freedman AN, Piver MS, Romero-Gutierrez M, Petrow E.

Gynecol Oncol. 1999 Dec;75(3):413-8.

PMID:
10600299
5.

p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?

Schwandner O, Bruch HP, Broll R.

Int J Colorectal Dis. 2002 Jan;17(1):11-9.

PMID:
12018448
6.

Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.

Lipponen P, Aaltomaa S, Eskelinen M, Ala-Opas M, Kosma VM.

Eur Urol. 1998 Sep;34(3):237-43.

PMID:
9732201
7.

p21(Waf1/Cip1) and p53 protein expression in breast cancer.

Wakasugi E, Kobayashi T, Tamaki Y, Ito Y, Miyashiro I, Komoike Y, Takeda T, Shin E, Takatsuka Y, Kikkawa N, Monden T, Monden M.

Am J Clin Pathol. 1997 Jun;107(6):684-91.

8.

Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.

Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.

Clin Cancer Res. 2004 Aug 1;10(15):5168-77.

10.
12.
13.

Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.

Liu XP, Tsushimi K, Tsushimi M, Kawauchi S, Oga A, Furuya T, Sasaki K.

Cancer Lett. 2001 Sep 20;170(2):183-9.

PMID:
11463497
14.

Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer.

Harada N, Gansauge S, Gansauge F, Gause H, Shimoyama S, Imaizumi T, Mattfeld T, Schoenberg MH, Beger HG.

Br J Cancer. 1997;76(3):299-305.

15.

Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma.

Liu XP, Kawauchi S, Oga A, Suehiro Y, Tsushimi K, Tsushimi M, Sasaki K.

Histopathology. 2001 Dec;39(6):603-10.

PMID:
11903579
16.

Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas.

Xie X, Clausen OP, Boysen M.

Arch Otolaryngol Head Neck Surg. 2002 Aug;128(8):897-902.

PMID:
12162767
18.

P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.

Hafkamp HC, Mooren JJ, Claessen SM, Klingenberg B, Voogd AC, Bot FJ, Klussmann JP, Hopman AH, Manni JJ, Kremer B, Ramaekers FC, Speel EJ.

Mod Pathol. 2009 May;22(5):686-98. doi: 10.1038/modpathol.2009.23.

20.

Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.

Hui AM, Kanai Y, Sakamoto M, Tsuda H, Hirohashi S.

Hepatology. 1997 Mar;25(3):575-9.

PMID:
9049201
Items per page

Supplemental Content

Support Center